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Summary. Of 24 published clinical reports of periodic
chronic myelogenous leukaemia (PCML), 21 had sufficient
data to analyse for periodicity, and 12 showed significant
periodicity ( p < 0·05) using the Lomb periodogram. Leuco-
cyte oscillations had periods T ranging from 37 to 83 d.
When data were also reported for platelets and reticulocytes
there was no significant difference between their periods and
those of the leucocytes. These data and their analysis provide
strong circumstantial evidence for a haemopoietic stem cell
origin of PCML. Namely, the known chromosomal changes
in CML patients may, on occasion, also be accompanied by a
destabilization resulting in an oscillatory efflux into the
leucocyte, platelet and erythrocytic pathways.
Keywords: chronic myelogenous leukaemia, periodicity,
spectral analysis, stem cell, apoptosis.
In 1967 four patients with CML whose leucocyte counts
showed gross and apparently spontaneous oscillations with
periods from 30 to 100 d were reported by Morley et al
(1967). Two of these patients also showed oscillations in the
platelet counts with the same periods as in the leucocyte
counts. Other cases of putative cyclic leucocytosis have
now been reported in CML (Chikkappa et al, 1976; Delobel
et al, 1973; Gatti et al, 1973; German et al, 1976; Iizuka et al,
1984; Inbal et al, 1983; Kennedy, 1970; Mastrangelo et al,
1974, 1976; Mehta & Agarwal, 1980; Rodriguez & Lutcher,
1976; Shadduck et al, 1972; Umemura et al, 1986; Vodopick
et al, 1972; Yamauchi & Ide, 1992). In most patients,
oscillations in the leucocyte counts were accompanied by
oscillations in the platelet and reticulocyte counts with the
same periodicity. The presence of oscillations in more than
one cell population strongly suggests that the oscillations
originate in the stem cell compartment.
We report here an analysis of previously published serial
blood counts from 24 PCML patients. Periodogram analysis
was used to test for the presence of statistically significant
periodic oscillations, and to find the phase relationship
between the different cell populations.
DATA AND METHODS
Cases of PCML have been reported in 24 different clinical
studies. Of these, the studies by German et al (1976) and
Mehta & Agarwal (1980) were rejected because the serial
blood counts were not included in the reports. Another was
rejected because the serial blood counts were truncated
(Shadduck et al, 1972). In the study by Kennedy (1970) the
patients were treated for CML with hydroxyurea, and in that
by Rodriguez & Lutcher (1976) they were treated with
busulphan. In Kennedy (1970) no data were available to us
before the initiation of hydroxurea therapy. However, the
data that we analysed were all collected during constant
hydroxurea dosage. In Rodriguez & Lutcher (1976) there
was clear evidence for cycling before initiation of bulsuphan
therapy which only decreased the amplitude of the cycling
and left the period unchanged. The other patients were not
treated for CML, which implied that the oscillations were
occurring naturally and not induced by treatment.
The published serial blood counts were initially scanned
and converted to PostScript files with Photoshop 4.0.
GhostView 2.2 was used to extract the time and value of
each data point, so a digitized version of the serial blood
counts could be used for statistical analysis.
The most commonly used technique for detecting
periodicity in a time series is the Fourier power spectrum,
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or periodogram. This technique is applicable when the data
are evenly sampled but can give erroneous results when the
data are unevenly sampled, which is usually the case for serial
blood counts. While studying celestial phenomena, astrophy-
sicists also encountered the problem of unevenly sampled data,
and they developed an extension of the Fourier power
spectrum (the Lomb periodogram) for evenly or unevenly
sampled data (Lomb, 1976). The statistical significance (p
value) of any peak can also be determined (Scargle, 1982).
Specifically, let xj be the number of a particular type of cell
as measured at times t j, where j ¼ 1, . . . , N and N is the
number of data points. As usual, the mean and variance of
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The value of P(T) indicates the likelihood of a periodicity
with period T in the data set. Given that the null hypothesis is
that the values xj are independent Gaussian random noise,
and that P(T) has an exponential probability distribution
with unit mean, the significance level ( p value) of any peak is
given by
p ; 1 ¹ 1 ¹ e¹PðTÞ
ÿ M
ð4Þ
where M < N (Press et al, 1992). When the significance level p
is small (significant), Equation 4 can be approximated to give
p < Me¹PðTÞ: ð5Þ
We implemented Equation 2 for a series of different periods
T. The estimation of the significance level of P(T ) is
straightforward as long as some criteria are satisfied for the
choice of the range and the number of periods that are scanned
(Scargle, 1982; Press et al, 1992). A data set was considered
periodic if the significance level p of the principal peak in the
periodogram satisfied p < 0·05 (5%). An adaptation of the
procedure proposed in Press et al (1992), using Matlab, was
used to analyse the digitized data. Free copies of this program
are available from the authors for the analysis of analogous
data for non-commercial purposes.
Once a significant periodicity of period T has been detected
through periodogram analysis, the estimation of the phase
(f) and amplitude (A) of the sine wave that fits best the data
can be calculated by a least squares fitting procedure (Lomb,
1976; Scargle, 1982) of the data Xj using





; j ¼ 1; :::;N ð6Þ
RESULTS
Periodogram analysis was performed on the serial blood
counts of 21 patients. Nine had apparent oscillations in the
leucocyte counts, but the analysis indicated that the
oscillations did not have a statistically significant period.
Three of these patients were reported by Morley et al (1967),
three were reported by Kennedy (1970) and one patient each
was reported by Inbal et al (1983), Mastrangelo et al (1974)
and Mastrangelo et al (1976). Significant periodic oscillations
were detected in all the other patients. Table I summarizes the
results of the determination of the periods T, their significance
levels p, and their phase shifts f relative to the leucocyte
oscillation. Figs 1–4 show the serial blood counts and the
periodogram analysis for each of these 12 patients.
Periodicities in the leucocyte, platelet, and reticulocyte counts
Fig 1 shows the serial blood counts and corresponding Lomb
periodogram of three patients with marked oscillations in the
leucocyte population. Typically, leucocyte counts oscillated
from normal to high values. Although no data were
published for the platelet and reticulocyte counts, Kennedy
(1970) and Gatti et al (1973) noted that their patients also
showed platelet oscillations with the same period as the
leucocytes. Dolobel et al (1973) did not mention if
oscillations were present in other cell lineages.
The serial blood counts and the corresponding Lomb
periodograms for six patients with both leucocyte and
platelet oscillations are shown in Figs 2 and 3. The two
cases reported by Vodopick et al (1972) also showed
variation in the reticulocyte counts, but with a much
smaller amplitude than in the leucocytes and platelets. (The
periodicities could not be established due to lack of data.) The
leucocyte and platelet counts of these two patients were
oscillating, with the same period, between normal and
elevated levels. Yamauchi & Ide (1992) reported that the
reticulocyte counts of their patient were stable, but the
leucocytes oscillated between normal and higher levels, and
the platelets oscillated around normal levels with the same
period as the leucocytes. The leucocyte counts of the patient
reported by Kennedy (1970) oscillated between normal and
high levels, but the platelets oscillated from normal to low
levels. Cyclic variations were not noted in the reticulocyte
counts. Morley et al (1967) reported oscillations between
normal and high levels in the leucocyte and platelet counts
of their patient, but the authors did not mention if the
reticulocyte counts were oscillating. The leucocyte and
platelet counts of the patient reported by Umemura et al
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Fig 1. Data and analysis for patients in which only leucocyte data were published. The left column contains serial blood counts of three patients
with oscillations in the leucocyte population, and the right column contains the corresponding Lomb periodogram P(T ) [ power P versus period T
in days]. The dashed line in the left column represents the normal level of cells, and the horizontal lines in the Lomb periodogram give the
p ¼ 0·05, p ¼ 0·01 and p ¼ 0·001 significance levels.
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Fig 2. Analysis of published leucocyte and platelet data for three patients. All other notation as in Fig 1.
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Fig 3. Analysis of published leucocyte and platelet data for three patients. All other notation as in Fig 1.
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Fig 4. Analysis of serial blood counts from three patients with oscillations in the leucocyte, platelet, and reticulocyte populations. All other
notation as in Fig 1.
(1986) oscillated from normal to high values, and the
reticulocyte counts did not appear to be oscillating.
Fig 4 shows the serial blood counts of three patients with
oscillations in the leucocyte, platelet, and reticulocyte
counts. Although there was a phase difference between the
three cell populations, the periodicities were the same. The
presence of a peak at 62 d in the reticulocyte periodogram of
the patient reported by Chikkappa et al (1976), though not
statistically significant, suggests an underlying oscillation in
the reticulocyte counts with the same period as the leucocyte
and platelet counts. Similarly, the peak at 36 d in the platelet
periodogram of the patient reported by Rodriguez & Lutcher
(1976) also suggests that the platelet counts oscillate with
the same period as the leucocyte and reticulocyte counts.
Phase relationship between oscillating populations of cells
To the eye, the leucocyte and platelet counts shown in Figs 2,
3 and 4 oscillated not only with the same period, but also
with the same phase. Only a least squares fitting procedure
could detect the phase differences. We found that oscillations
in the platelet counts led (were ahead of) the leucocyte
oscillations by 6–13 d.
In contrast to the platelet counts, the reticulocyte counts in
Fig 4 were easily seen to be almost 1808 out of phase with the
leucocytes. The reticulocyte counts of the patient reported by
Iizuka et al (1984) were either ahead of the leucocyte counts by
24 d, or they lagged by 33 d. Similarly, the reticulocyte counts
of the patient reported by Rodriguez & Lutcher (1976) were
either 17 d ahead of the leucocyte counts, or they lagged by
20 d. For the patient reported by Chikkappa et al (1976), the
reticulocyte counts were half a period (1808) out of phase with
respect to the leucocytes. The phase shift in days of the
reticulocyte counts did not appear to be constant from patient
to patient, but after converting them to degrees they were seen
to oscillate 1808 out of phase with respect to the leucocytes,
irrespective of the period of oscillation.
DISCUSSION
Our analysis shows that PCML is a periodic blood disorder with
some characteristics similar to those observed in cyclical
neutropenia (CN) (Haurie et al, 1998a). In both diseases,
oscillations in one or more cell populations are present, and
usually the populations oscillate with the same period. A phase
shift between the oscillating populations has also been noticed
in CN, but it was not as consistent as that observed in PCML
(Haurie et al, 1998a). It is unclear how the oscillations of CN
arise, but there is strong circumstantial evidence that an
instability in the HSC is responsible for the induction of these
cycles (Haurie et al, 1998a; Jones et al, 1975a, b; Weiden et al,
1974; Krance et al, 1982; Patt et al, 1973) and that this
instability is due to an elevated rate of HSC apoptosis (Haurie
et al, 1998b; Mackey, 1978, 1996). Further, a connection has
been established between cyclical neutropenia and idiopathic
and congenital neutropenia (in which there is an elevated rate
of apoptosis) (Haurie et al, 1998b).
The observations of this paper strongly suggest that
the origin of the oscillations in PCML, as in CN, is located in
the HSC such that there is cyclical differentiation efflux to the
more mature cells. Given the derangements of apoptosis
implicated in CML (Amarante-Mendes et al, 1998; Clarkson
et al, 1997; Gisslinger et al, 1997; Maguer-Satta et al, 1998;
Sattler & Salgia, 1997; Seong et al, 1998; Wright et al,
1998), we speculate that in PCML there is a HSC instability
induced by decreased apoptotic rates such that an oscillatory
efflux from the HSC gives rise to the oscillations in the
peripheral blood cell counts analysed here.
Further evidence for a stem cell origin comes from
theoretical investigations of the stem cell dynamics. A
mathematical model of the stem cell population, which takes
into account the presence of a delay due to a finite proliferation
time, was shown to produce oscillations with periods in the
range reported here (Mackey, 1978, 1979, 1996).
It is completely unclear as to what extent PCML may occur
q 1999 Blackwell Science Ltd, British Journal of Haematology 104: 336–345
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Table I. Periodicities (in days) estimated through periodogram analysis (6the uncertainty) with their significance level (p value), and the relative
phase shift of platelets and reticulocytes with respect to leucocytes.
Period (days) and p value Phase shift (d)
Reference Leucocytes Platelets Reticulocytes Platelets Reticulocytes
Kennedy (1970) 58 6 1 (3 × 10¹3) –* –† –§ –§
Delobel et al (1973) 73 6 5 (2 × 10¹6) –‡ –‡ –§ –§
Gatti et al (1973) 71 6 2 (5 × 10¹10) –* –† –§ –§
Vodopick et al (1972) 70 6 4 (7 × 10¹8) 64 6 4 (3 × 10¹8) –* 9·1 6 2·5 –§
Vodopick et al (1972) 54 6 3 (1 × 10¹6) 54 6 3 (2 × 10¹7) –* 10·2 6 1·4 –§
Yamauchi & Ide (1992) 70 6 2 (1 × 10¹4) 70 6 2 (3 × 10¹3) –† 10·7 6 2·7 –§
Kennedy (1970) 43 6 1 (2 × 10¹3) 42 6 1 (3 × 10¹6) –† 5·9 6 2·4 –§
Morley et al (1967) 54 6 14 (3 × 10¹3) 53 6 14 (1 × 10¹2) –‡ 9·5 6 1·6 –§
Umemura et al (1986) 83 6 12 (2 × 10¹5) 83 6 11 (2 × 10¹4) –† 13·2 6 2·2 –§
Iizuka et al (1984) 57 6 2 (2 × 10¹6) 55 6 2 (5 × 10¹2) 55 6 2 (5 × 10¹4) 5·9 6 2·1 24·3 6 2·4
Chikkappa et al (1976) 63 6 3 (2 × 10¹2) 59 6 3 (9 × 10¹4) 62 6 3 (7 × 10¹1) 9·7 6 3·5 31·9 6 5·6
Rodriguez & Lutcher (1976) 37 6 3 (2 × 10¹2) 36 6 3 (2 × 10¹1) 37 6 3 (3 × 10¹3) 8·6 6 2·7 16·7 6 1·9
* Oscillating, but data not published. † Not apparently oscillating. ‡ Data not published and no comments by author concerning periodicity.
§ Since data were not available for platelets and/or reticulocytes, the phase shift could not be calculated.
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in the entire population of CML patients. This lack of
knowledge concerning the frequency with which PCML
occurs is largely related to the paucity of the serial clinical
data usually available on CML patients. Though it is difficult
to obtain an analytic rule of thumb connecting the number
N of data points required to establish the existence of a cycle
of period T with significance p using the definition of the
Lomb periodogram, it can easily be used to do this
numerically. We generated a sine wave of amplitude A and
period T with added Gaussian distributed white noise with
variance j2, and determined the relation between the
number N and the significance level p with which T could
be determined for a given ratio of the amplitude of the sine
wave to the standard deviation j. This ratio is called the
signal-to-noise ratio (SNR) and is usually expressed in dB and
in terms of root-mean-square values. In the present case, the
SNR can be written as







Fig 5 shows the significance level p with which the period T
of these noisy test signals can be determined as a function of
the number of data points N and three SNRs. (The lower line is
that of a pure sine wave without added noise and fixes the
lower bound on the significance level.) The SNRs used were 1,
5 and 10 dB (corresponding to ratios A/j of about 1·6, 2·5
and 4·5). For a pure sine wave (no noise), a minimum of 13
data points is required to detect a periodic oscillation with
p < 0·05). Similarly, a minimum of 16 data points is required
for a typical 5 dB signal. If one wishes to establish a cycle with
a period of 2 months and with a significance level of 0·5, then
the following criteria should be satisfied. Blood samples should
be obtained at least once a month (Nyquist frequency) for a
minimum of 16 months, twice a month for a minimum of 8
months, or once a week for 4 months.
The data of Fig 5 indicate that the detection PCML would
require a sampling frequency that is higher and more
regular than is currently standard practice. The detection of
these oscillations in CML patients may help to take a more
informed decision concerning the choice of treatment.
Fig 5. Significance level (p) for signals with
different number of data points (N) and signal-
to-noise ratio (SNR). W, 1 dB SNR; K, 5 dB
SNR; A, 10 dB SNR; L, pure sine wave.
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